Current Pharmaceutical Design

William A. Banks  
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA

Back

Editorial: The Different Facets of Diabetes, Dyslipidemia and Hypertension in Cardio-metabolic Diseases: Current Perspective and Future Developments free to download

Volume:23   Issue:10
Pp: 1425-1426
Joseph Fomusi Ndisang
DOI: 10.2174/138161282310170512174010

Order Reprints Order Eprints

Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases

Volume:23   Issue:10
Pp: 1427-1434
Emina Sudar-Milovanovic, Sonja Zafirovic, Aleksandra Jovanovic, Jovana Trebaljevac, Milan Obradovic, Desanka Cenic-Milosevic and Esma R. Isenovic
DOI: 10.2174/1381612823666170124124855

Order Reprints Order Eprints

Potential Role for Dendritic Cells in Endothelial Dysfunction, Diabetes and Cardiovascular Disease

Volume:23   Issue:10
Pp: 1435-1444
Astrid Parenti, Laura Pala, Sara Paccosi and Carlo Maria Rotella
DOI: 10.2174/1381612823666170124125826

Order Reprints Order Eprints

Vascular Remodelling in Well-controlled Hypertensive Patients: The Challenge of Residual Risk Management

Volume:23   Issue:10
Pp: 1445-1452
Massimo Puato, Chiara Nardin, Marta Zanon, Paolo Palatini, Paolo Pauletto and Marcello Rattazzi
DOI: 10.2174/1381612823666170228122644

Order Reprints Order Eprints

Metabolic and Cardiovascular Actions of Nesfatin-1: Implications in Health and Disease

Volume:23   Issue:10
Pp: 1453-1464
Naresh Ramesh, Kavishankar Gawli, Venkata Kiran Pasupulleti and Suraj Unniappan
DOI: 10.2174/1381612823666170130154407

Order Reprints Order Eprints

Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management

Volume:23   Issue:10
Pp: 1471-1476
Valeria Raparelli, Susanna Morano, Flavia Franconi, Andrea Lenzi and Stefania Basili
DOI: 10.2174/1381612823666170130153704

Order Reprints Order Eprints

Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia

Volume:23   Issue:10
Pp: 1484-1494
Joel Schmitz and Ioanna Gouni-Berthold
DOI: 10.2174/1381612823666170130155036

Order Reprints Order Eprints

Proteoglycans and Diabetes

Volume:23   Issue:10
Pp: 1500-1509
Linda M. Hiebert
DOI: 10.2174/1381612823666170125154915

Order Reprints Order Eprints

SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature

Volume:23   Issue:10
Pp: 1510-1521
Konstantinos Imprialos, Charles Faselis, Chrysoula Boutari, Konstantinos Stavropoulos, Vasilios Athyros, Asterios Karagiannis and Michael Doumas
DOI: 10.2174/1381612823666170124123927

Order Reprints Order Eprints

Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management

Volume:23   Issue:10
Pp: 1522-1532
Niki Katsiki, Dimitri P. Mikhailidis and Michael J. Theodorakis
DOI: 10.2174/1381612823666170113152742

Order Reprints Order Eprints

Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun

Volume:23   Issue:10
Pp: 1540-1550
Charles Faselis, Chrysoula Boutari, Michael Doumas, Konstantinos Imprialos, Konstantinos Stavropoulos and Peter Kokkinos
DOI: 10.2174/1381612823666170206154706

Order Reprints Order Eprints

Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases

Volume:23   Issue:10
Pp: 1551-1561
Milan Obradovic, Julijana Stanimirovic, Anastasija Panic, Nikola Bogdanovic, Emina Sudar-Milovanovic, Desanka Cenic-Milosevic and Esma R. Isenovic
DOI: 10.2174/1381612823666170203113455

Order Reprints Order Eprints